Response to oral supplementation in copper deficiency myeloneuropathy
- PMID: 18772693
- DOI: 10.1097/CND.0b013e3181828cf7
Response to oral supplementation in copper deficiency myeloneuropathy
Abstract
Neurological manifestations due to copper deficiency include ataxic myeloneuropathy that resembles subacute combined degeneration due to B12 deficiency. We report our experience in the treatment of 10 patients with copper deficiency myeloneuropathy and conclude that copper supplementation leads to stabilization rather than improvement in the neurological deficits.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
